|
Recommend Human Vaccines to your librarian for 2008. Download form here. Table of Contentsseptember/october 2007volume 3| issue 5 |
|
Letter
Assessing the Safety of Post-Exposure Rabies Immunization in Pregnancy
Subhash C. Arya and Nirmala AgarwalVolume: 3 | Issue: 5 | Page 155
ELISA Assays for Rabies Antibodies?
Gerlind Anders and Hoshang B. VakilVolume: 3 | Issue: 5 | Page 156
Research Paper
Vaxfectin-Formulated Influenza DNA Vaccines Encoding NP and M2 Viral Proteins Protect Mice against Lethal Viral Challenge
Gretchen S. Jimenez, Rodrick Planchon, Qun Wei, Denis Rusalov, Andrew Geall, Joel Enas, Peggy Lalor, Vicky Leamy, Ruth Vahle, Catherine J. Luke, Alain Rolland, David C. Kaslow and Larry R. SmithVolume: 3 | Issue: 5 | Pages: 157 - 164
Open Access Article
Rabies Antibody Levels in Bat Handlers in the United Kingdom: Immune Response Before and After Purified Chick Embryo Cell Rabies Booster Vaccination
Jill Morris, Natasha S. Crowcroft, Anthony R. Fooks and Nick AndrewsVolume: 3 | Issue: 5 | Pages: 165 - 170
Trust and Experience as Predictors of HPV Vaccine Acceptance
Laura A.V Marlow, Jo Waller and Jane WardleVolume: 3 | Issue: 5 | Pages: 171 - 175
A Retrospective Study on the Quality of Haemophilus Influenzae Type B Vaccines Used in the U.K. Between 1996 and 2004
Barbara Bolgiano, Fatme Mawas, Karena Burkin, Dennis T. Crane, Manolya Saydam, Peter Rigsby and Michael J. CorbelVolume: 3 | Issue: 5 | Pages: 176 - 182
Immunogenicity of Two Modern Tissue Culture Rabies Vaccines in Pre-Exposure Prophylaxis
P.S. Kulkarni, Sidram K. Raut, Suresh S. Jadhav, Subhash V. Kapre and Nileema DeuskarVolume: 3 | Issue: 5 | Pages: 183 - 186
Anticapsular Polysaccharide IgG Concentrations in Mexican Children Formerly Immunized with Haemophilus Influenzae b Prp-T Vaccine
Patricia Gómez de León, F. Javier Díaz García, Jose Luis Arredondo, Jorge Jorge, Silvia Giono Cerezo and Jose I. SantosVolume: 3 | Issue: 5 | Pages: 187 - 191
Use of Neutralizing Murine Monoclonal Antibodies to Rabies Glycoprotein in Passive Immunotherapy Against Rabies
K. Muhamuda, S.N. Madhusudana and V. RaviVolume: 3 | Issue: 5 | Pages: 192 - 195
Post-Marketing Safety Monitoring of a New Group B Meningococcal Vaccine in New Zealand, 2004-2006
Anne McNicholas, Yvonne Galloway, Paul Stehr-Green, Stewart Reid, Sarah Radke, Kerry Sexton, Charlotte Kieft, Claire Macdonald, Jocelyn Neutze, Ross Drake, Dorothy Isaac, Mary O'Donnell, Michael Tatley, Philipp Oster and Jane O'HallahanVolume: 3 | Issue: 5 | Pages: 196 - 204
Open Access Article
Safety, Reactogenicity, and Immunogenicity of a Recombinant Protective Antigen Anthrax Vaccine Given to Healthy Adults
James D. Campbell, Kristin H. (Long) Clement, Steven S. Wasserman, Sarah Donegan, Lisa Chrisley and Karen L. KotloffVolume: 3 | Issue: 5 | Pages: 205 - 211
Knowledge of Spanish Parents About Their Childrens Vaccinations During the Decade 1993-2003
P. Carrasco-Garrido, A. Gil de Miguel, V. Hernandez Barrera and R. Jimenez-GarciaVolume: 3 | Issue: 5 | Pages: 212 - 216
Commentary
Vaccination and Risk Groups: How Can We Really Protect the Weakest?
Paolo BonanniVolume: 3 | Issue: 5 | Pages: 217 - 219
Optimisation of Oral Immunization Through Receptor-Mediated Targeting of M Cells
A. Ruth Foxwell, Allan W. Cripps and Jennelle M. KydVolume: 3 | Issue: 5 | Pages: 220 - 223
Open Access Article
Immune Surveillance as a Rationale for Immunotherapy?
Anastas Pashov, Behjatolah Monzavi-Karbassi, Marie Chow, Martin Cannon and Thomas Kieber-EmmonsVolume: 3 | Issue: 5 | Pages: 224 - 228




